Publications and communications of Alexandre Hego

Legrand, C., Vanneste, D., Hego, A., Sabatel, C., Mollers, K., Schyns, J., Maréchal, P., Abinet, J., Tytgat, A., Liégeois, M., Polese, B., Meunier, M., Radermecker, C., Fievez, L., Bureau, F., & Marichal, T. (2024). Lung Interstitial Macrophages Can Present Soluble Antigens and Induce Foxp3+ Regulatory T Cells. American Journal of Respiratory Cell and Molecular Biology. doi:10.1165/rcmb.2023-0254OC

Layios, N., Gosset, C., Maes, N., Delierneux, C., Hego, A., Huart, J., LECUT, C., DAMAS, P., Oury, C., & Gothot, A. (2023). Prospective flow cytometry analysis of leucocyte subsets in critically ill patients who develop sepsis: a pilot study. Infection. doi:10.1007/s15010-023-01983-3

Janssen, P.* , Tosi, I.* , Hego, A., Maréchal, P., Marichal, T.* , & Radermecker, C.*. (13 July 2022). Neutrophil Extracellular Traps Are Found in Bronchoalveolar Lavage Fluids of Horses With Severe Asthma and Correlate With Asthma Severity. Frontiers in Immunology, 13. doi:10.3389/fimmu.2022.921077
* These authors have contributed equally to this work.

Jacques, S., Arjomand, A., Perée, H., COLLINS, P., Mayer, A., Lavergne, A., Wéry, M., Mni, M., Hego, A., Thuillier, V., Becker, G., Bahri, M. A., Plenevaux, A., Di Valentin, E., Oury, C., MOUTSCHEN, M., Delvenne, P., Paquot, N., & Rahmouni, S. (2021). Dual‑specificity phosphatase 3 deletion promotes obesity, non‑alcoholic steatohepatitis and hepatocellular carcinoma. Scientific Reports, 11, 5817. doi:10.1038/s41598-021-85089-6

Anania, S., Peiffer, R., Rademaker, G., Hego, A., Thiry, M., Deldicque, L., Francaux, M., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (21 June 2020). Myoferlin is a yet unknown interactor of the mitochondrial dynamics’ machinery in pancreas cancer cells. Cancers, 12 (6), 1643. doi:10.3390/cancers12061643

Anania, S., Rademaker, G., Peiffer, R., Hego, A., Deldicque, L., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (February 2020). Role of myoferlin in mitochondrial dynamics and metabolic fitness of pancreas cancer [Poster presentation]. BACR Annual Meeting 2020 - Cancer metastases: from bedside to bench, Brussels, Belgium.

Lombard, A., Di Gregorio, M., COPPIETERS, N., Di Valentin, E., Hego, A., Martin, D., & Rogister, B. (2020). Communicating hydrocephalus associated to ventral leptomeningeal invasion leads to precocious death in a glioblastoma orthotopic xenograft model. Neuro-Oncology Advances.

Oury, C., MARECHAL, P., Donis, N., Hulin, A., Hego, A., TRIDETTI, J., Nguyen, M.-L., DULGHERU, R. E., Fillet, M., Nchimi Longang, A., & Lancellotti, P. (2020). Dexfenfluramine and Pergolide Cause Heart Valve Disease via Valve Metabolic Reprogramming and Ongoing Matrix Remodeling. International Journal of Molecular Sciences, 21 (11). doi:10.3390/ijms21114003

Kautbally, S., Lepropre, S., Onselaer, M.-B., Le Rigoleur, A., Ginion, A., De Meester de Ravenstein, C., Ambroise, J., Boudjeltia, K. Z., Octave, M., WERA, O., Hego, A., PINCEMAIL, J., Cheramy-Bien, J.-P., Huby, T., Giera, M., Gerber, B., Pouleur, A.-C., Guigas, B., Vanoverschelde, J.-L., ... Beauloye, C. (September 2019). Platelet Acetyl-CoA Carboxylase Phosphorylation: A Risk Stratification Marker That Reveals Platelet-Lipid Interplay in Coronary Artery Disease Patients. JACC: Basic to Translational Science, 4 (5), 596-610. doi:10.1016/j.jacbts.2019.04.005

Hulin, A., Hego, A., Lancellotti, P., & Oury, C. (2018). Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets. Frontiers in Cardiovascular Medicine, 5, 21. doi:10.3389/fcvm.2018.00021

Lepropre, S., Kautbally, S., Octave, M., Ginion, A., Onselaer, M.-B., Steinberg, G. R., Kemp, B. E., Hego, A., Wéra, O., Brouns, S., Swieringa, F., Giera, M., Darley-Usmar, V. M., Ambroise, J., Guigas, B., Heemskerk, J., Bertrand, L., Oury, C., Beauloye, C., & Horman, S. (2018). AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation. Blood, 132 (11), 1180-1192. doi:10.1182/blood-2018-02-831503

Musumeci, L., Jacques, N., Hego, A., Nchimi Longang, A., Lancellotti, P., & Oury, C. (2018). Prosthetic Aortic Valves: Challenges and Solutions. Frontiers in Cardiovascular Medicine, 5, 46. doi:10.3389/fcvm.2018.00046

LAYIOS, N., Delierneux, C., Hego, A., HUART, J., GOSSET, C., LECUT, C., MAES, N., Geurts, P., Joly, A., LANCELLOTTI, P., Albert, A., DAMAS, P., GOTHOT, A., & Oury, C. (December 2017). Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study. Intensive Care Medicine Experimental, 5 (1), 32. doi:10.1186/s40635-017-0145-2

Wéra, O., Delierneux, C., Hego, A., LECUT, C., Servais, L., Nchimi Longang, A., LANCELLOTTI, P., & Oury, C. (2016). P2X1 ion channel is critical for vascular integrity in inflammation [Poster presentation]. ESC CONGRESS, ROMA, Italy.

LECUT, C., PETERS, P., FIORE, M., Delierneux, C., JOIRET, M., Hego, A., Oury, C., & GOTHOT, A. (20 November 2015). Phenotypic characterization of a patient with Glanzmann Thrombasthenia caused by a novel homozygous mutation in the ITGA2B gene [Poster presentation]. 23ème congrès annuel de la Société Belge de Thrombose-Hémostase, Mechelen, Belgium.

Oury, C., Hego, A., & LANCELLOTTI, P. (November 2015). L'image du mois : Le processus thrombotique sous la loupe (microscopie intravitale). Revue Médicale de Liège, 70 (11), 537-539.

Rahmouni, S., MUSUMECI, L., Kuijpers, M. J., Gilio, K., Hego, A., Theatre, E., Senis, Y., Heemskerk, J., Thiry, M., Tautz, L., & Oury, C. (24 June 2015). DUSP3 Phosphatase Deficiency or Inhibition Limits Platelet Activation and Arterial Thrombosis [Paper presentation]. ISTH 2015 Congress, Toronto, Canada.

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., MUSUMECI, L., Rahmouni, S., BOURS, V., LANCELLOTTI, P., & Oury, C. (22 June 2015). CLEC-2 is required for the activation of mouseplatelets by bacterial DNA mimetics [Paper presentation]. ISTH 2015 Congress, Toronto, Canada.

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., MUSUMECI, L., Rahmouni, S., BOURS, V., Lancellotti, P., & Oury, C. (22 June 2015). CLEC-2 is required for the activation of mouse platelets by bacterial DNA mimetics [Paper presentation]. ISTH 2015 Congress, Toronto, Canada.

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., Musumeci, L., Rahmouni, S., Thiry, M., Compère, P., BOURS, V., Lancellotti, P., & Oury, C. (27 January 2015). Bacterial DNA mimetics activate platelets and promote thrombosis via CLEC-2 [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

LANCELLOTTI, P., NCHIMI LONGANG, A., Delierneux, C., Hego, A., Gosset, C., Gothot, A., TSHIBANDA, L., & Oury, C. (2015). Biological Effects of Cardiac Magnetic Resonance on Human Blood Cells. Circulation: Cardiovascular Imaging, 8 (9). doi:10.1161/CIRCIMAGING.115.003697

LAYIOS, N., Delierneux, C., Hego, A., HUART, J., Joly, A., Geurts, P., DAMAS, P., LECUT, C., Gothot, A., & Oury, C. (2015). Erratum: Elevated basal levels of circulating activated platelets predict ICU-acquired sepsis and mortality: a prospective study. Critical Care, 19 (1), 301. doi:10.1186/s13054-015-1005-7

LAYIOS, N., GOSSET, C., Delierneux, C., Hego, A., HUART, J., DAMAS, P., Oury, C., & GOTHOT, A. (2015). Prospective immune profiling in critically ill adults : before, during and after severe sepsis shock. Critical Care, 19 (1).

LAYIOS, N., GOSSET, C., Delierneux, C., Hego, A., HUART, J., Joly, A., Geurts, P., DAMAS, P., Oury, C., & Gothot, A. (2015). Erratum: Prospective immune profiling in critically ill adults: before, during and after severe sepsis and septic shock. Critical Care, 19 (1), 300. doi:10.1186/s13054-015-1006-6

Oury, C., Hego, A., & Lancellotti, P. (2015). L'image du mois: Le processus thrombotique sous la loupe (microscopie intravitale). Revue Médicale de Liège, 70 (11), 537-539.